What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Efflux, Escherichia coli, Microbiology, Multiple drug resistance and Drug resistance.
His Efflux study deals with the bigger picture of Biochemistry.
His Escherichia coli research focuses on Membrane transport protein and how it relates to Integral membrane protein and Bacterial outer membrane.
His Microbiology research includes themes of Enterobacteriaceae and Salmonella.
His studies in Multiple drug resistance integrate themes in fields like Response regulator, Signal transduction, Binding site and Transcription factor.
His study in Drug resistance is interdisciplinary in nature, drawing from both Plasmid and Novobiocin.
His most cited work include:
- Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli (499 citations)
- Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. (256 citations)
- Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium (249 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Efflux, Microbiology, Escherichia coli, Multiple drug resistance and Drug resistance.
His Efflux study incorporates themes from Plasmid, Novobiocin, Mutant and Bacterial outer membrane.
His Microbiology research is multidisciplinary, incorporating perspectives in Salmonella enterica, Salmonella, Bacteria and Virulence.
His work carried out in the field of Escherichia coli brings together such families of science as Molecular biology, Membrane transport protein and Response regulator.
His work deals with themes such as Regulator, Operon and Pseudomonas aeruginosa, which intersect with Multiple drug resistance.
His Drug resistance research includes elements of Xenobiotic, Drug and Bacterial genome size.
He most often published in these fields:
- Efflux (77.42%)
- Microbiology (73.39%)
- Escherichia coli (49.19%)
What were the highlights of his more recent work (between 2015-2020)?
- Efflux (77.42%)
- Microbiology (73.39%)
- Multiple drug resistance (38.71%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Efflux, Microbiology, Multiple drug resistance, Pseudomonas aeruginosa and Biophysics.
His biological study spans a wide range of topics, including Bacterial outer membrane and Mutant, Transporter, Gene.
The study incorporates disciplines such as Drug and Virulence in addition to Microbiology.
His work in Virulence addresses subjects such as Plasmid, which are connected to disciplines such as Salmonella.
His Multiple drug resistance research is multidisciplinary, relying on both Regulator, Biotechnology and Pharmaceutical microbiology.
Kunihiko Nishino works mostly in the field of Binding site, limiting it down to topics relating to Multidrug transporter and, in certain cases, Escherichia coli, as a part of the same area of interest.
Between 2015 and 2020, his most popular works were:
- A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa (41 citations)
- Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition (36 citations)
- Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa. (23 citations)
In his most recent research, the most cited papers focused on:
Efflux, Mutant, Biophysics, Pseudomonas aeruginosa and Binding site are his primary areas of study.
Kunihiko Nishino has researched Efflux in several fields, including Multidrug Resistance-Associated Proteins, Plasma protein binding and Membrane transport protein.
His Mutant research is multidisciplinary, relying on both Multiple drug resistance, Steric effects, Stereochemistry and Transmembrane domain.
His Biophysics research is multidisciplinary, incorporating elements of Amino acid, Random coil, Transport protein and Allosteric regulation.
Kunihiko Nishino combines subjects such as Amikacin, Antibiotic resistance and Microbiology with his study of Pseudomonas aeruginosa.
His Binding site study combines topics in areas such as Transporter, Escherichia coli, Multidrug transporter, Pulmonary surfactant and Substrate.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
